The Cost-Effectiveness of Canagliflozin Versus Sitagliptin...

Value in Health 2015 / 05 Vol. 18; Iss. 3

The Cost-Effectiveness of Canagliflozin Versus Sitagliptin as Third-Line Therapy in Type 2 Diabetes Mellitus (T2dm) in a Canadian setting

Sabapathy, S., Neslusan, C., Yoong, K., Teschemaker, A.R., Johansen, P., Willis, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.03.355
Date:
May, 2015
File:
PDF, 51 KB
english, 2015
Conversion to is in progress
Conversion to is failed